News

The latest news from British Patient Capital

Press release 27 November 2023

British Patient Capital – Full Year Results for the period ending 31 March 2023

Investing in tomorrow: British Patient Capital’s total fund and co-investment commitments reach £1.9bn.

Read Press release

Filter news

Showing 1 - 10 of 86 results

Sort by:

British Patient Capital announces investment into Purespring Therapeutics as part of £80m Series B financing round

Press release 09 October 2024

British Patient Capital makes €25m commitment to Blume Equity Fund I to support companies tackling climate change

Press release 17 September 2024

British Patient Capital announces total $60m commitment to Atomico’s latest funds

Press release 16 September 2024

British Patient Capital Invests £10m in Form3

Press release 10 September 2024

British Patient Capital announces total $90m commitment to Balderton IX and Balderton Growth II

Press release 12 August 2024

British Patient Capital announces €35m commitment to Kennet VI

Partners and Programmes 29 July 2024

British Patient Capital announces £25m commitment to 13books Capital’s latest Fund

Press release 17 July 2024

Louis Taylor appointed Chair of British Patient Capital

Press release 09 July 2024

British Patient Capital announces investment into Myricx Bio as part of a £90m Series A financing round

Press release 08 July 2024

British Patient Capital announces follow-on investment into Grey Wolf Therapeutics as part of a $50m Series B financing expansion

Press release 23 May 2024